Clinical Trial Update: Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intra-arterial hepatic infusion of radiolabeled somatostatin analogs in patients with gastroenteropancreatic neuroendocrine tumors and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteropancreatic Neuroendocrine Tumor
• Liver Metastases
• Neuroendocrine Tumor

Drugs mentioned

• Radiolabeled somatostatin analogs

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Neuroendocrine Tumor, Liver Metastases | Phase 2 | Status: RECRUITING